Craft

JanOne

Stock Price

$2.3

2024-09-12

Market Capitalization

$27.1 M

2024-09-12

Revenue

$24.8 M

FY, 2025

JanOne Summary

Company Summary

Overview
JanOne (formerly known as ARCA) is a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. Its first drug candidate is a treatment for the peripheral arterial disease (PAD), a condition that can cause severe pain.
Type
Public
Status
Active
Founded
2019
HQ
Las Vegas, NV, US | view all locations
Website
https://janone.com/
Cybersecurity rating
Sectors

Key People

  • Tony Isaac, CEO

    • Virland A. Johnson

      Virland A. Johnson, Chief Financial Officer

      • Tony Giordano

        Tony Giordano, Chief Scientific Officer

        • Amol Soin

          Amol Soin, Chief Medical Officer

        LocationsView all

        1 location detected

        • Las Vegas, NV HQ

          United States

          325 E Warm Springs Rd #102

        JanOne Financials

        Summary Financials

        Revenue (Q1, 2026)
        $4.7M
        Gross profit (Q1, 2026)
        $3.6M
        Net income (Q1, 2026)
        ($271.5M)
        Cash (Q1, 2026)
        $10.5M
        EBIT (Q1, 2026)
        ($2.7M)
        Enterprise value
        $45.2M

        Footer menu